Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer

View source ↗

Summary

An observational study evaluating Tarceva (erlotinib) in patients with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Status: COMPLETED